Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It can also be more cost-effective
In the SURMOUNT-1 trial, participants on 10mg achieved an average weight reduction of 21.4%, losing roughly 49 pounds over 72 weeks
weight loss by people not meeting guidelines), and safety/ethical issues, especially in direct-to-consumer contexts
But how replicable is that data
Tirzepatide targets two hormone pathways, while Retatrutide is studied for triple-pathway signaling
US$ 21.75
US$ 21.33
US$ 20.01
US$ 28.05
